Imagine a future where we can unlock the secrets of strokes and revolutionize cardiovascular care. This is the ambitious vision driving a team of researchers at the University of Sydney, and their groundbreaking work is already making waves.
Unveiling the Power of 3D Printed Blood Vessels
Meet Charles Zhao, a PhD candidate with a unique background in mechanical engineering. Inspired by the desire to create something with a profound human impact, Charles embarked on a journey into biomedical engineering. His expertise in fluid dynamics became a powerful tool in understanding the intricate flow of blood within our vessels.
The team's innovative approach involves 3D printing blood vessels on glass, creating anatomically accurate replicas of healthy and diseased vessel segments. These delicate engravings on glass mimic the intricate anatomy of blood vessels, including the dents and divots often seen in stroke patients. By using CT scans of stroke patients as blueprints, the researchers have developed a method to shrink these models down to a fraction of their original size, making them ideal for study.
But here's where it gets controversial...
While traditional 3D printing methods are time-consuming and error-prone, the team has developed a new technique that uses glass slides as a base, reducing manufacturing time significantly. This breakthrough not only speeds up the process but also enhances accuracy, a critical factor in diagnosing and treating cardiovascular diseases.
And this is the part most people miss...
Cardiovascular disease is the leading cause of mortality in Australia, with a staggering statistic: one person loses their life to heart disease every 12 minutes. Despite well-established diagnosis methods, there is currently no way to predict the early events that lead to blood clots in carotid arteries. This is where the team's research shines a light, offering hope for millions at risk of stroke worldwide.
"We're not just printing blood vessels; we're printing hope," Charles Zhao emphasizes. "With continued support and collaboration, we aim to make personalized vascular medicine a reality for every patient who needs it."
The model, dubbed the 'artery on a chip', successfully mimics the physical appearance and fluid dynamics of blood vessels. This was a significant breakthrough, as recreating the complex flow of blood inside vessels is one of the biggest challenges in this field. The team's method provides an invaluable tool for studying the causes of stroke and testing new medications tailored to individual patient needs.
During testing, the researchers witnessed, in real-time, the formation of blood clots and the behavior of platelets, a crucial component in blood clotting. The technology revealed that the friction and force created by blood flow against the vessel lining play a significant role in platelet movement, especially in conditions like high blood pressure and atherosclerosis.
In areas of high stress on the blood vessels, the researchers observed up to 10 times more platelet movement. This finding highlights the importance of understanding the intricate dynamics within our blood vessels and how they contribute to the risk of blood clots and stroke.
"Imagine a future where we can rapidly print a patient's blood vessel model, test their blood response, and use AI to predict their stroke risk years in advance," says Professor Arnold Ju, the lab head and senior author. "We're creating a 'physical twin' of patient blood vessels, an exact replica that behaves like the real thing."
The team's work is a testament to the power of collaboration and innovation. By integrating artificial intelligence with their biofabrication platform, they aim to create 'digital twins' that can predict stroke events before they occur, shifting the focus from reactive treatment to proactive prevention.
Professor Ju emphasizes the exceptional collaborative efforts across the University of Sydney's School of Biomedical Engineering, Charles Perkins Centre, and the Heart Research Institute. He expresses deep gratitude for the visionary support of the Snow Medical Research Foundation and the Snow Family, whose fellowships have been instrumental in advancing this transformative research.
"We're not just printing blood vessels; we're printing hope for millions at risk of stroke worldwide. With continued support and collaboration, we aim to make personalized vascular medicine accessible to every patient who needs it," Professor Ju concludes.
The researchers have applied for funding opportunities, and if successful, they plan to recruit patients for pre-clinical trials. This groundbreaking work has the potential to revolutionize cardiovascular care and save countless lives.
What do you think about this innovative approach to studying strokes? Could this technology be a game-changer in the field of medicine? We'd love to hear your thoughts in the comments below!
